Skip to main content

Table 4 SOCS 4 - 7 Mean mRNA expression levels

From: Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer

Patient and tumour characteristics

SOCS4 Mean (SD)

P

SOCS5 Mean (SD)

P

SOCS6 Mean (SD)

P

SOCS7 Mean (SD)

P

ER Status

   ER(-) vs. ER(+)

198 (834) vs. 296 (1035)

0.63

1669 (2950) vs. 1066 (2215)

0.25

450 (1209) vs. 2018 (5905)

0.13

2310 (8080) vs. 715 (1341)

0.11

Tumor Grade

   Grade 1 vs. 2

142 (540) vs. 554 (1468)

0.13

834 (2468) vs. 2164 (3270)

0.09

2110 (7427) vs. 968 (2171)

0.51

5459 (14250) vs. 1396 (2583)

0.22

   Grade 1 vs. 3

142 (540) vs. 113 (380)

0.82

834 (2468) vs. 2076 (5191)

0.17

2110 (7427) vs. 475 (1267)

0.34

5459 (14250)

0.13

   Grade 2 vs. 3

554 (1468) vs. 113 (380)

0.07

2164 (3270) vs. 2076 (5191)

0.92

968 (2171) vs. 475 (1267)

0.21

vs. 427 (1339) 1396 (2583) vs. 427 (1339)

0.037

NPI

   NPI 1 vs. 2

276 (1004) vs. 168 (513)

0.49

1742(2846) vs. 1715 (3064)

0.97

1117 (4564) vs. 687 (1610)

0.51

2740 (8754) vs. 518 (1189)

0.06

   NPI 1 vs. 3

276 (1004) vs. 419 (1441)

0.72

1742 (2846) vs. 3132 (9006)

0.56

117 (4564) vs. 439 (1138)

0.31

2740 (8754) vs. 538 (1125)

0.07

   NPI 2 vs. 3

168 (513) vs. 419 (1441)

0.52

1715 (3064) vs. 3132 ( 9006)

0.56

687 (1610) vs. 439 (1138)

0.53

518 (1189) vs. 538 (1125)

0.95

TNM

   TNM 1 vs. 2

384 (1208) vs. 180 (532)

0.25

1856 (3095) vs. 2328 (6035)

0.66

552 (1217) vs. 1925 (5786)

0.16

2239 (7923) vs. 1329 (4566)

0.47

   TNM 1 vs. 3

384(1208) vs. 75 (198)

0.08

1856 (3095) vs. 1521(3114)

0.8

552 (1217) vs. 93 (217)

0.01

2239 (7923) vs. 137 (353)

0.04

   TNM 1 vs. 4

384 (1208) vs. 1.5 (3)

0.02

1856 (3095) vs. 0.26 (0.53)

0.00

552 (1217) vs. 156 (33.7)

0.001

2239 (7923) vs. 0.004 (0.008)

0.03

   TNM 2 vs. 3

180 (532) vs. 75 (198)

0.37

2328 (6035) vs. 1521 (3114)

0.61

1925 (5786) vs. 93 (217)

0.06

1329 (4566) vs. 137 (353)

0.13

   TNM 2 vs. 4

180 (532) vs. 1.5 (3)

0.049

2328 (6035) vs. 0.26( 0.53)

0.03

1925 (5786) vs. 22.8 (33.7)

0.05

1329 (4566) vs. 0.004 (0.008)

0.09

   TNM 3 vs. 4

75 (198) vs. 1.5 (3)

0.36

1521 (3114) vs. 0.26 (0.53)

0.24

93 (217) vs. 22.8 (33.7)

0.43

137 (353) vs. 0.004 (0.008)

0.35

Survival

   DF vs. LR

146 (566) vs. 959 (2223)

0.37

1551 (2851) vs. 1807 (2315)

0.79

994 (3987) vs. 776 (1311)

0.75

2110 (7490) vs. 271 (716)

0.04

   DF vs. DR

146 (566) vs. 2.1 (3.3)

0.024

1551 (2851) vs. 10190 (14338)

0.25

994 (3987) vs. 372 (582)

0.23

2110 (7490) vs. 246 (500)

0.03

   DF vs. D

146 (566) vs. 685 (1577)

0.23

1551 (2851) vs. 1190 (2787)

0.66

994 (3987) vs. 825 (1967)

0.81

2110 (7490) vs. 467 (1232)

0.07

  1. SOCS 4 - 7 Mean mRNA expression levels in a cohort of 128 breast cancer patients; a comparison between subgroups with different tumour grade, NPI score, and TNM stage. SD: Standard deviation, DF: Disease free survival, LR: Local disease recurrence, DR: Distant disease recurrence, D: Death from breast cancer